09:56 EST Corbus Pharmaceuticals trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRBP:
- Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Corbus Pharmaceuticals reports Q3 EPS ($2.27) vs ($2.11) last year
- Corbus Pharmaceuticals presents results on CRB-601 at 2023 SITC meeting
- Corbus Pharmaceuticals announce publication of CRB-913
- Corbus Pharmaceuticals presents pre-clinical characterization of CRB-701